Nancey, A
751  results:
Search for persons X
?
3

P927 Long-term outcomes of risankizumab in Crohn's disease:..:

Fumery, M ; Caron, B ; Hébuterne, X...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i1686-i1686 , 2024
 
?
4

P807 HLA type impact on immunization and efficacy of usteki..:

Delmeule, A ; Dubois, V ; gay, C...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i1503-i1503 , 2024
 
?
5

P884 Patient satisfaction and experience after a switch to ..:

Bouguen, G ; Gossec, L ; Abitbol, V...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i1627-i1627 , 2024
 
?
6

DOP79 Promising efficacy of biologicals and small molecules..:

Verstockt ., B ; Taelman, T ; Vavricka, S R...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i219-i221 , 2024
 
?
7

P578 CDST (Clinical Decision Support Tool) is predictive of..:

Buisson, A ; Nancey, S ; Dodel, M...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i1129-i1129 , 2024
 
?
8

P857 Effectiveness and safety of subcutaneous infliximab in..:

Andre, M ; Kirchgesner, J ; Laharie, D...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i1587-i1587 , 2024
 
?
9

P322 Compared Efficacy of Second-Line Treatments for Ulcera..:

Calmejane, L ; Reenaers, C ; Amiot, A...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i707-i707 , 2024
 
?
11

DOP23 The role of histology for the prediction of clinical ..:

Reenaers Dr, C ; Enea, D ; Nachury, M...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i117-i117 , 2024
 
?
 
1-15